Explore luminescence screening assays for drug discovery, including luciferase and ATP assays. Learn the principles, formats, advantages, and limitations.
Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.
One recent obstacle to drug delivery research is an observed weak correlation between in vitro and in vivo performance. When nanoparticles are applied intravenously, they face several obstacles that ...
Hosted on MSN
From lab bench to AI: the future of enzyme assays
Enzyme assays are evolving from traditional spectrophotometric methods to high-throughput, AI-powered platforms that accelerate drug discovery, diagnostics, and sustainable chemistry. Advances like ...
As AI accelerates target discovery and pushes more candidates toward the bench, assay development and transfer have become critical bottlenecks. Teams relying on one-factor-at-a-time (OFAT) workflows ...
CD Bioparticles Announces Services For Colloidal Gold Lateral Flow Assays To Accelerate Point-Of-Care Diagnostics. EINPresswire/ -- With years of experience in the pharmaceutical and life science ...
We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen environmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results